Showing results (131-140 of 279) with videos related to
Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
High-resolution human genome structure by single-molecule analysisBrian Teague, Michael S Waterman, Steven Goldstein, et al.Plos Genetics|January 30, 2018
Transcriptional regulatory control of mammalian nephron progenitors revealed by multi-factor cistromic analysis and genetic studiesLori L O'Brien, Qiuyu Guo, Emad Bahrami-Samani, et al.Leukemia Research|June 19, 2022
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center databaseNoa Rippel, Douglas Tremblay, Nicole Zubizarreta, et al.Leukemia Research|June 3, 2021
Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional databaseDouglas Tremblay, Lukas Ronner, Nikolai Podoltsev, et al.Archives of Pathology & Laboratory Medicine|April 11, 2019
Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the <i>BRAF</i>, <i>EGFR</i>, and <i>KRAS</i> Genes: A Study of the College of American Pathologists Molecular Oncology CommitteeJoel T Moncur, Angela N Bartley, Julia A Bridge, et al.JAMA Oncology|December 16, 2017
Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS TestingAnnette S Kim, Angela N Bartley, Julia A Bridge, et al.The New England Journal of Medicine|August 13, 2004
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CMLCatriona H M Jamieson, Laurie E Ailles, Scott J Dylla, et al.Journal of Hematology & Oncology|October 1, 2017
Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analysesSrdan Verstovsek, Jason Gotlib, Ruben A Mesa, et al.Archives of Pathology & Laboratory Medicine|October 31, 2018
Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology AssaysJason D Merker, Kelly Devereaux, A John Iafrate, et al.The Journal of Allergy and Clinical Immunology|April 14, 2022
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?Peter Valent, Cem Akin, Karin Hartmann, et al.Pageof 28